Ahead of #WorldCancerDay on Sunday 4th February, we are delighted announce our support to the Alderley Park and Bionow event ‘Accelerating Cancer Drug Development – From Target to Patients’.
Taking Place on 27th February at Alderley Park Conference Centre, our Group Leader Thomas Pesnot will be giving a talk titled ‘Tailoring Screening Libraries for Neuro-Oncology using Multiparameter Optimisation’.
Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation (patients), this event will highlight industry, academic and clinical strengths whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.
The event will cover sessions on:
New Target Identification & Chemistry
Preclinical: PK ADME, Toxicology
Clinical Trials and how Clinical decisions made
Imaging, Diagnostics, Pathology & Screening
Keynote speakers include Susan Galbraith, VP of Oncology at AstraZeneca and Prof Rob Bristow, Director of Cancer Research UK Manchester Centre and Chief Academic Officer at The Christie NHS Foundation Trust.